SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001104659-22-028294
Filing Date
2022-03-01
Accepted
2022-03-01 06:07:37
Documents
10
Effectiveness Date
2022-03-01

Document Format Files

Seq Description Document Type Size
1 POSASR tm227954d1_posasr.htm POSASR 436532
2 EXHIBIT 5.1 tm227954d1_ex5-1.htm EX-5.1 38761
3 EXHIBIT 23.1 tm227954d1_ex23-1.htm EX-23.1 2620
4 EX-FILING FEES tm227954d1_ex-filingfee.htm EX-FILING FEES 42197
5 GRAPHIC tm227954d1_ex5-1img001.jpg GRAPHIC 6373
6 GRAPHIC tm227954d1_ex5-1img002.jpg GRAPHIC 2599
7 GRAPHIC tm227954d1_posasrimg0001.jpg GRAPHIC 19274
8 GRAPHIC tm227954d1_posasrimg001.jpg GRAPHIC 6079
9 GRAPHIC tm227954d1_posasrsp5img001.jpg GRAPHIC 5769
10 GRAPHIC tm227954d1_posasrsp5img002.jpg GRAPHIC 5487
  Complete submission text file 0001104659-22-028294.txt   584870
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-258426 | Film No.: 22693714
SIC: 2834 Pharmaceutical Preparations